Burst Biologics is a research-focused biotechnology company that develops groundbreaking products in the cutting-edge field of regenerative medicine. An in-house team of Ph.D. scientists is focused on researching large molecule pharmaceuticals and the potential to impact life-altering conditions. At Burst, product quality is a top priority. Burst's onsite laboratory maintains control of each production stage to ensure optimal consistency and quality in every product. Burst Biologics provides premium products for both surgical and clinical applications. Tissue products offered by Burst have three main composition components: umbilical cord blood (UCB), cancellous bone, and amniotic tissue.